Mondaq USA: Food, Drugs, Healthcare, Life Sciences
Troutman Sanders LLP
For agreeing not to challenge Natural American Spirit's use of the word "Natural" in its product packaging and labeling, the U.S. Food and Drug Administration ("the FDA") has been sued...
Jones Day
As Jones Day analyzed last month, the government has increased scrutiny of Medicare incentive payments for meaningful use of EHR technology.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Congress needs to legislatively grant HRSA more administrative authority over the 340B Drug Discount Program.
Duff and Phelps
The S&P Healthcare Services Index increased 1.0% over the last month, outperforming the S&P 500, which increased 0.9% over the same period.
Reed Smith
While the Capitol Hill spotlight is focused on the Senate debate on legislation to repeal or revise the Affordable Care Act, the House of Representatives quietly approved by voice vote HR 3178, the Medicare Part B Improvement Act of 2017.
Duff and Phelps
The S&P Healthcare Services index increased 5.8% over the past month, outperforming the S&P 500, which increased 1.8% over the same period.
Day Pitney LLP
On July 25, the U.S. Department of Health and Human Services' Office for Civil Rights (OCR) announced that it has implemented several changes to its web-based breach-reporting portal (commonly referred to as the "Wall of Shame"), which lists healthcare data breaches of 500 or more patient records dating back to 2009.
Smith Gambrell & Russell LLP
Late yesterday, Mitch McConnell, Senate Majority Leader (R.KY.) announced that the Senate will delay its summer recess for two weeks.
Wilson Elser Moskowitz Edelman & Dicker LLP
In this month's edition of Health Care Provider Insights, we provide the following insights to help you protect your practice.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Our colleagues at ML Strategies have provided their Health Care Weekly Preview for the week of July 24, 2017.
Seyfarth Shaw LLP
One of the hottest topics in the food, beverage and dietary supplement industries, for both producers and advertisers, remains the disclosure of genetically modified organisms, or ‘GMOs,' in these products.
Reed Smith
CMS has published its proposed rule to update Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) payment system rates and policies for calendar year (CY) 2018.
Holland & Knight
Senate Majority Leader Mitch McConnell this weekend delayed plans to hold a procedural vote this week to move forward with the Senate's Better Care Reconciliation Act (BCRA) healthcare reform bill...
Holland & Knight
On July 14, 2017, Donah Heiberg, with the Bureau of Field Operations for the Florida Agency for Health Care Administration's Office of Health Quality Assurance gave a presentation to District X of the Florida Health Care Association.
Day Pitney LLP
On July 24, the New Jersey Supreme Court ruled that Horizon Blue Cross Blue Shield of New Jersey must turn over the internal report it used in determining the composition of its tiered OMNIA health plan.
Ropes & Gray LLP
The United States Food & Drug Administration (FDA) has issued a guidance document announcing its intention not to object to an IRB's waiving or altering the informed consent requirements for an FDA-regulated clinical investigation that presents no more than minimal risk and involves adequate human subjects protections.
Dickinson Wright PLLC
On July 13, the Nevada Tax Commission held a public hearing to discuss the potential marijuana product shortfall facing the state's dispensaries following the launch of state-authorized recreational marijuana sales in Nevada on July 1.
Seyfarth Shaw LLP
This is the one hundred and tenth issue in our series of alerts for employers on selected topics on health care reform.
Smith Gambrell & Russell LLP
As soon as the revised health care bill was introduced yesterday, criticism began and the margin for passage may already be compromised.
Holland & Knight
The U.S. Senate Republicans on July 13, 2017, released an updated discussion draft of the Better Care Reconciliation Act of 2017 (BCRA), its bill to repeal and replace the Affordable Care Act (ACA).
Latest Video
Most Popular Recent Articles
Akin Gump Strauss Hauer & Feld LLP
Despite the headlines coming out of Washington, Congress continues to move forward in regular fashion, discussing and acting upon key issues, such as funding the government, addressing the need...
Day Pitney LLP
A June 1 article, "Blue Cross Exec Tests HIPAA By Describing $12M Patient," in Law360 provides an analysis of a recent incident in which a Wellmark Blue Cross & Blue Shield executive made a public comment about a patient who has accrued $12 million in annual medical bills.
Reed Smith
In a tacit acknowledgement of the hurdles ahead for enactment of Affordable Care Act (ACA) repeal/replace legislation, the Trump Administration is soliciting suggestion for changes that could be made within the current legal framework to improve health insurance markets and meet Administration reform goals.
Reed Smith
The Supreme Court decided "the big one" today – and not to keep anyone in suspense [the big one is a major earthquake in California mass tort litigation]...
Arnold & Porter Kaye Scholer LLP
The law also authorizes an additional $500 million over 10 years to an FDA Innovation Account to help the Agency carry out these new authorities.
Duane Morris LLP
On June 8, 2017, Clifford J. White III, director of the U.S. Trustee Program, proclaimed before a congressional subcommittee that "debtors with assets or income derived from marijuana may not proceed...
Reed Smith
We have two posts on innovator liability that we update on a consistent basis: our innovator liability scorecard...
Schnader Harrison Segal & Lewis LLP
We thought you might be interested in today's U.S. Supreme Court decision Bristol-Myers Squibb Co. v. Superior Court of California.
Hyman, Phelps, & McNamara, P.C.
It's been a couple of months since the dust has settled from FDA's October 26, 2016 approval of Mylan Pharmaceuticals Inc.'s ANDA 078276 for a generic version of Daiichi Sankyo Inc.'s BENICAR Tablets...
Poyner Spruill LLP
Apparently prompted by the recent high-profile wave of ransomware attacks, the Department of Health and Human Services' Office of Civil Rights has reminded hospitals, healthcare systems...
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with